Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells



The Company
Stemline Therapeutics, Inc. is a clinical stage biotechnology company developing oncology compounds directed towards cancer stem cell targets.
Pipeline
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called "StemScreen®" to identify novel compounds that target and kill CSCs.


News
&
Events
7/20/2010
CEO of Stemline to present at Drug Development Conference Aug. 4, 2010
3/21/2010
Stemline CEO invited speaker at Cancer Stem Cell conference Mar. 24-25, 2010
12/4/2009
Stemline announces presentation of SL-401 and SL-501 activity in CML at ASH
Copyright 2008 - Stemline Therapeutics, Inc. All rights reserved
Stemline